1. Abbott Gmbh & Co Kg (28 from 140 patents)

2. Abbvie Deutschland Gmbh and Co Kg (17 from 167 patents)

3. Basf Aktiengesellschaft (6 from 10,754 patents)

4. Other (1 from 832,880 patents)

5. Abbott Laboratories Corporation (1 from 4,179 patents)

6. Abbott Gmbh & Co. Hg (1 from 1 patent)

7. Abbvie Bahamas Limited (6 patents)

1. 9487505 - Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them

2. 9475782 - Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors

3. 9434713 - 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseases

4. 9422264 - Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases

5. 9403796 - Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses

6. 9296697 - [object Object]

7. 9238642 - Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses

8. 9023854 - 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressin-dependent diseases

9. 9006276 - Substituted oxindole derivatives, medicaments containing said derivatives and use thereof

10. 8921406 - 5-ring heteroaromatic compounds and their use as binding partners for 5-HT5 receptors

11. 8859557 - Substituted oxindole derivatives and their use as vasopressin receptor ligands

12. 8815868 - Substituted oxindole derivatives and their use as vasopressin receptor ligands

13. 8791148 - Substituted benzimidazolone derivatives, medicaments comprising them and their use

14. 8703775 - Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses

15. 8703774 - Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases